- Home
- OLN vs AXSM Comparison
OLN vs AXSM Comparison
Compare OLN & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLN
- AXSM
- Stock Information
- Founded
- OLN 1892
- AXSM 2012
- Country
- OLN United States
- AXSM United States
- Employees
- OLN N/A
- AXSM N/A
- Industry
- OLN Major Chemicals
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- OLN Industrials
- AXSM Health Care
- Exchange
- OLN Nasdaq
- AXSM Nasdaq
- Market Cap
- OLN 3.9B
- AXSM 4.2B
- IPO Year
- OLN N/A
- AXSM 2015
- Fundamental
- Price
- OLN $33.76
- AXSM $91.94
- Analyst Decision
- OLN Buy
- AXSM Strong Buy
- Analyst Count
- OLN 16
- AXSM 14
- Target Price
- OLN $48.81
- AXSM $125.54
- AVG Volume (30 Days)
- OLN 1.7M
- AXSM 988.5K
- Earning Date
- OLN 01-30-2025
- AXSM 02-18-2025
- Dividend Yield
- OLN 2.37%
- AXSM N/A
- EPS Growth
- OLN N/A
- AXSM N/A
- EPS
- OLN 1.24
- AXSM N/A
- Revenue
- OLN $6,483,400,000.00
- AXSM $338,457,000.00
- Revenue This Year
- OLN N/A
- AXSM $44.77
- Revenue Next Year
- OLN $5.90
- AXSM $67.70
- P/E Ratio
- OLN $27.29
- AXSM N/A
- Revenue Growth
- OLN N/A
- AXSM 51.47
- 52 Week Low
- OLN $30.69
- AXSM $64.11
- 52 Week High
- OLN $60.60
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- OLN 44.21
- AXSM 53.83
- Support Level
- OLN $32.88
- AXSM $79.19
- Resistance Level
- OLN $33.81
- AXSM $95.36
- Average True Range (ATR)
- OLN 0.92
- AXSM 4.65
- MACD
- OLN 0.44
- AXSM 1.14
- Stochastic Oscillator
- OLN 76.82
- AXSM 82.72
About OLN Olin Corporation
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.